EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Management of Cerebral Amyloid Angiopathy

Aikaterini Theodorou iD, Stella Fanouraki iD, Eleni Bakola iD, Georgia Papagiannopoulou iD, Lina Palaiodimou iD, Maria Chondrogianni iD, Maria-Ioanna Stefanou iD, Lampis Stavrinou, Athanasia Athanasaki iD, Klearchos Psychogios iD, Odysseas Kargiotis iD, Apostolos Safouris iD und 3 weitere

Journal of Clinical Medicine · 15.06.2025 · 14 (12) · 4259

DOI: 10.3390/jcm14124259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.06.2025. Verfasst von Aikaterini Theodorou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, Chaidari…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral amyloid angiopathy (CAA) represents a progressive cerebrovascular disorder, characterized by aberrant accumulation of beta-amyloid isoforms in cortical and leptomeningeal vessel walls of cerebrum and cerebellum.

Methods

We sought to investigate the clinical manifestations, current different diagnostic tools, various therapeutic strategies and most uncommon subtypes of the disease.

Results

The vast majority of CAA remains sporadic, with increasing prevalence with age and very frequent coexistence with Alzheimer’s disease. Clinically, CAA can present with spontaneous lobar intracerebral hemorrhage, transient focal neurologic episodes attributed to convexity subarachnoid hemorrhage or cortical superficial siderosis, and progressive cognitive decline leading to dementia. Inflammatory CAA subtype should be recognized early and treated promptly so that better functional outcomes may be achieved. Moreover, genetic and iatrogenic CAA forms are rare, yet increasingly recognized during the last years. Therapeutic management remains challenging for clinicians, especially when markers indicative of higher bleeding risk are present. A targeted therapy does not currently exist. However, various clinical trials are in progress, focusing on offering new promising insights into the disease treatment.

Conclusions

This review aims to deepen our understanding of CAA diagnosis and therapeutic approach but also summarizes current evidence on the most uncommon subtypes of this cerebral small-vessel disease.

Schlagwörter

Stichwörter der Autor:innen

CAA-riamyloid PETamyloid-βbrain MRIcerebral amyloid angiopathycerebral microbleedscerebrospinal fluid biomarkerscortical superficial siderosistreatment

Autor:innen und Institutionen

  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, Chaidari, 12462 Athens, Greece.
  • Department of Neurology & Stroke, Eberhard-Karls University of Tübingen, 72074 Tübingen, Germany.
  • Hertie Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, 72074 Tübingen, Germany.
  • Second Department of Neurosurgery, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Stroke Unit, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Second Department of Radiology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.

ORCID-Profile: Aikaterini Theodorou, Stella Fanouraki, Eleni Bakola, Georgia Papagiannopoulou, Lina Palaiodimou, Maria Chondrogianni, Maria-Ioanna Stefanou, Athanasia Athanasaki, Klearchos Psychogios, Odysseas Kargiotis, Apostolos Safouris, Georgios Velonakis, Georgios P Paraskevas, Georgios Tsivgoulis

Zitieren

APA

Theodorou, A., Fanouraki, S., Bakola, E., Papagiannopoulou, G., Palaiodimou, L., Chondrogianni, M., Stefanou, M. I., Stavrinou, L., Athanasaki, A., Psychogios, K., Kargiotis, O., Safouris, A., Velonakis, G., Paraskevas, G. P., & Tsivgoulis, G. (2025). Clinical Management of Cerebral Amyloid Angiopathy. Journal of Clinical Medicine, 14(12), 4259. https://doi.org/10.3390/jcm14124259

Vancouver

Theodorou A, Fanouraki S, Bakola E, Papagiannopoulou G, Palaiodimou L, Chondrogianni M, et al. Clinical Management of Cerebral Amyloid Angiopathy. Journal of Clinical Medicine. 2025;14(12):4259. doi:10.3390/jcm14124259

BibTeX
@article{Theodorou2025,
  author = {Theodorou, Aikaterini and Fanouraki, Stella and Bakola, Eleni and Papagiannopoulou, Georgia and Palaiodimou, Lina and Chondrogianni, Maria and Stefanou, Maria-Ioanna and Stavrinou, Lampis and Athanasaki, Athanasia and Psychogios, Klearchos and Kargiotis, Odysseas and Safouris, Apostolos and Velonakis, Georgios and Paraskevas, Georgios P and Tsivgoulis, Georgios},
  title = {Clinical Management of Cerebral Amyloid Angiopathy},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4259},
  doi = {10.3390/jcm14124259}
}
Kostenlos starten →